BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32795402)

  • 1. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
    Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
    Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage.
    Lança T; Ungerbäck J; Da Silva C; Joeris T; Ahmadi F; Vandamme J; Svensson-Frej M; Mowat AM; Kotarsky K; Sigvardsson M; Agace WW
    Immunity; 2022 Aug; 55(8):1431-1447.e11. PubMed ID: 35830859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
    Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
    Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and functional interaction among Irf8 enhancers during dendritic cell differentiation.
    Yamasaki T; Nishiyama A; Kurogi N; Nishimura K; Nishida S; Kurotaki D; Ban T; Ramilowski JA; Ozato K; Toyoda A; Tamura T
    Cell Rep; 2024 Apr; 43(4):114107. PubMed ID: 38613785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BATF-JUN is critical for IRF4-mediated transcription in T cells.
    Li P; Spolski R; Liao W; Wang L; Murphy TL; Murphy KM; Leonard WJ
    Nature; 2012 Oct; 490(7421):543-6. PubMed ID: 22992523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
    Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
    Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes.
    Glasmacher E; Agrawal S; Chang AB; Murphy TL; Zeng W; Vander Lugt B; Khan AA; Ciofani M; Spooner CJ; Rutz S; Hackney J; Nurieva R; Escalante CR; Ouyang W; Littman DR; Murphy KM; Singh H
    Science; 2012 Nov; 338(6109):975-80. PubMed ID: 22983707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.
    Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S
    J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
    Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
    Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development.
    Yamamoto M; Kato T; Hotta C; Nishiyama A; Kurotaki D; Yoshinari M; Takami M; Ichino M; Nakazawa M; Matsuyama T; Kamijo R; Kitagawa S; Ozato K; Tamura T
    PLoS One; 2011; 6(10):e25812. PubMed ID: 22003407
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Liu TT; Ou F; Belk JA; Bagadia P; Anderson DA; Durai V; Yao W; Satpathy AT; Murphy TL; Murphy KM
    Genes Dev; 2023 Apr; 37(7-8):291-302. PubMed ID: 36990511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who on IRF are you? IRF8 deficiency redirects cDC1 lineage commitment.
    Waller K; Scott CL
    Trends Immunol; 2022 Sep; 43(9):687-689. PubMed ID: 35963772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative profiling of BATF family proteins/JUNB/IRF hetero-trimers using Spec-seq.
    Chang YK; Zuo Z; Stormo GD
    BMC Mol Biol; 2018 Mar; 19(1):5. PubMed ID: 29587652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc finger-IRF composite elements bound by Ikaros/IRF4 complexes function as gene repression in plasma cell.
    Ochiai K; Kondo H; Okamura Y; Shima H; Kurokochi Y; Kimura K; Funayama R; Nagashima T; Nakayama K; Yui K; Kinoshita K; Igarashi K
    Blood Adv; 2018 Apr; 2(8):883-894. PubMed ID: 29669755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia.
    Pang SH; Minnich M; Gangatirkar P; Zheng Z; Ebert A; Song G; Dickins RA; Corcoran LM; Mullighan CG; Busslinger M; Huntington ND; Nutt SL; Carotta S
    Leukemia; 2016 Jun; 30(6):1375-87. PubMed ID: 26932576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular choreography of IRF4 and IRF8 with immune system partners.
    Singh H; Glasmacher E; Chang AB; Vander Lugt B
    Cold Spring Harb Symp Quant Biol; 2013; 78():101-4. PubMed ID: 24752218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
    Bagadia P; Huang X; Liu TT; Durai V; Grajales-Reyes GE; Nitschké M; Modrusan Z; Granja JM; Satpathy AT; Briseño CG; Gargaro M; Iwata A; Kim S; Chang HY; Shaw AS; Murphy TL; Murphy KM
    Nat Immunol; 2019 Sep; 20(9):1174-1185. PubMed ID: 31406377
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
    Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional reprogramming by mutated IRF4 in lymphoma.
    Schleussner N; Cauchy P; Franke V; Giefing M; Fornes O; Vankadari N; Assi SA; Costanza M; Weniger MA; Akalin A; Anagnostopoulos I; Bukur T; Casarotto MG; Damm F; Daumke O; Edginton-White B; Gebhardt JCM; Grau M; Grunwald S; Hansmann ML; Hartmann S; Huber L; Kärgel E; Lusatis S; Noerenberg D; Obier N; Pannicke U; Fischer A; Reisser A; Rosenwald A; Schwarz K; Sundararaj S; Weilemann A; Winkler W; Xu W; Lenz G; Rajewsky K; Wasserman WW; Cockerill PN; Scheidereit C; Siebert R; Küppers R; Grosschedl R; Janz M; Bonifer C; Mathas S
    Nat Commun; 2023 Nov; 14(1):6947. PubMed ID: 37935654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
    Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
    J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.